INT178890

From wiki-pain
(Difference between revisions)
Jump to: navigation, search
(Generated page)
 

Latest revision as of 01:24, 23 September 2012

Context Info
Confidence 0.62
First Reported 2004
Last Reported 2011
Negated 1
Speculated 1
Reported most in Body
Documents 12
Total Number 13
Disease Relevance 15.76
Pain Relevance 1.49

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

mitochondrion (CHDH)
Anatomy Link Frequency
coronary artery 5
blood 1
CHDH (Homo sapiens)
Pain Link Frequency Relevance Heat
cva 48 99.36 Very High Very High Very High
ischemia 5 98.28 Very High Very High Very High
cytokine 3 93.08 High High
Percutaneous transluminal coronary angioplasty 7 92.88 High High
headache 20 88.32 High High
Migraine 77 84.24 Quite High
aspirin 21 82.24 Quite High
Bile 80 80.88 Quite High
dopamine receptor 2 77.04 Quite High
depression 6 72.80 Quite High
Disease Link Frequency Relevance Heat
Coronary Artery Disease 772 100.00 Very High Very High Very High
Nicotine Addiction 68 100.00 Very High Very High Very High
Increased Venous Pressure Under Development 63 100.00 Very High Very High Very High
Disease 59 100.00 Very High Very High Very High
Coronary Heart Disease 38 100.00 Very High Very High Very High
Atherosclerosis 9 99.98 Very High Very High Very High
Cardiovascular Disease 170 99.74 Very High Very High Very High
Pressure And Volume Under Development 20 99.60 Very High Very High Very High
Disorder Of Lipid Metabolism 776 99.54 Very High Very High Very High
Diabetes Mellitus 52 99.40 Very High Very High Very High

[edit] Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Our approach takes into account the pre-test coronary risk, the expected distribution of CAC scores adjusted for all conventional CHD risk factors, and summary adjusted relative risks from a recent meta-analysis, and provides clinically relevant post-test risk estimates that may be directly useful to primary care physicians, cardiologists and patients as they decide whether or not to take medications for primary prevention of CHD.
Neg (prevention) Localization (prevention) of CHD associated with coronary artery disease
1) Confidence 0.62 Published 2004 Journal BMC Med Section Body Doc Link PMC515311 Disease Relevance 0.97 Pain Relevance 0
Secondary prevention of CHD involves risk factor reduction through control of health behaviors such as diet, physical activity, smoking and medication adherence using a coordinated approach and referrals to health professionals [2,3].
Localization (prevention) of CHD associated with nicotine addiction and coronary artery disease
2) Confidence 0.61 Published 2006 Journal BMC Health Serv Res Section Body Doc Link PMC1590021 Disease Relevance 0.87 Pain Relevance 0.04
In our search for articles about the benefits of physician knowledge of global CHD risk scores, we included studies of any design that met the following criteria: (1) study population consisted of adults (>18 years old) with no prior history of CVD; (2) global CHD risk calculation was specified as the primary study intervention; (3) there was clear documentation of the calculation of a global CHD risk score by a physician or other health care provider as part of an individual patient encounter (Note: questionnaire-based studies were considered acceptable as long as they were designed to simulate clinical encounters with patients); and (4) one or more of the following endpoints was used: (i) rates of prescribing for aspirin, anti-hypertensive medication, lipid-lowering medication, smoking cessation therapies, or diet and exercise; (ii) physician compliance with guidelines for CVD prevention; (iii) patient adherence with therapy; (iv) change in patient blood pressure, cholesterol levels, aspirin use, smoking cessation, diet or exercise; or (v) rate of CVD events (defined here as new onset stroke/transient ischemic attack, myocardial infarction, acute coronary syndrome, stable angina, peripheral vascular disease, carotid artery disease, or cardiac death).
Localization (calculation) of CHD in blood associated with aspirin, acute coronary syndrome, angina, nicotine addiction, coronary artery disease, cv general 4 under development, stroke, increased venous pressure under development, cardiovascular disease, hypertension, carotid artery diseases, death and myocardial infarction
3) Confidence 0.44 Published 2008 Journal BMC Health Serv Res Section Body Doc Link PMC2294118 Disease Relevance 1.53 Pain Relevance 0.14
According to ATP III, the risk factors for CHD are cigarette smoking, hypertension (>140/90 mmHg), low HDL-C (<40 mg/dL), family history of premature CHD (CHD in first degree relative, male <55 years old and female <65 years old), and age (male >45 years old and female >55 years old).3 People who have previously had CHD (including MI, angina, coronary artery procedures, and myocardial ischemia) or who have a CHD risk equivalent (history of diabetes, noncoronary atherosclerotic disease such as peripheral vascular disease, or 2 or more risk factors for CHD with a 10 year CHD risk of >20%) are considered high risk patients whose LDL-C goal should be <100 mg/dL or <70 mg/dL.3,4
Localization (disease) of CHD in coronary artery associated with pressure and volume under development, nicotine addiction, coronary artery disease, atherosclerosis, diabetes mellitus, ischemia, increased venous pressure under development, disease, cva and disorder of lipid metabolism
4) Confidence 0.41 Published 2010 Journal Vascular Health and Risk Management Section Body Doc Link PMC2835557 Disease Relevance 1.73 Pain Relevance 0.10
According to ATP III, the risk factors for CHD are cigarette smoking, hypertension (>140/90 mmHg), low HDL-C (<40 mg/dL), family history of premature CHD (CHD in first degree relative, male <55 years old and female <65 years old), and age (male >45 years old and female >55 years old).3 People who have previously had CHD (including MI, angina, coronary artery procedures, and myocardial ischemia) or who have a CHD risk equivalent (history of diabetes, noncoronary atherosclerotic disease such as peripheral vascular disease, or 2 or more risk factors for CHD with a 10 year CHD risk of >20%) are considered high risk patients whose LDL-C goal should be <100 mg/dL or <70 mg/dL.3,4
Localization (had) of CHD in coronary artery associated with pressure and volume under development, nicotine addiction, coronary artery disease, atherosclerosis, diabetes mellitus, ischemia, increased venous pressure under development, disease, cva and disorder of lipid metabolism
5) Confidence 0.41 Published 2010 Journal Vascular Health and Risk Management Section Body Doc Link PMC2835557 Disease Relevance 1.84 Pain Relevance 0.15
According to ATP III, the risk factors for CHD are cigarette smoking, hypertension (>140/90 mmHg), low HDL-C (<40 mg/dL), family history of premature CHD (CHD in first degree relative, male <55 years old and female <65 years old), and age (male >45 years old and female >55 years old).3 People who have previously had CHD (including MI, angina, coronary artery procedures, and myocardial ischemia) or who have a CHD risk equivalent (history of diabetes, noncoronary atherosclerotic disease such as peripheral vascular disease, or 2 or more risk factors for CHD with a 10 year CHD risk of >20%) are considered high risk patients whose LDL-C goal should be <100 mg/dL or <70 mg/dL.3,4
Localization (cigarette) of CHD in coronary artery associated with pressure and volume under development, nicotine addiction, coronary artery disease, atherosclerosis, diabetes mellitus, ischemia, increased venous pressure under development, disease, cva and disorder of lipid metabolism
6) Confidence 0.41 Published 2010 Journal Vascular Health and Risk Management Section Body Doc Link PMC2835557 Disease Relevance 1.86 Pain Relevance 0.15
According to ATP III, the risk factors for CHD are cigarette smoking, hypertension (>140/90 mmHg), low HDL-C (<40 mg/dL), family history of premature CHD (CHD in first degree relative, male <55 years old and female <65 years old), and age (male >45 years old and female >55 years old).3 People who have previously had CHD (including MI, angina, coronary artery procedures, and myocardial ischemia) or who have a CHD risk equivalent (history of diabetes, noncoronary atherosclerotic disease such as peripheral vascular disease, or 2 or more risk factors for CHD with a 10 year CHD risk of >20%) are considered high risk patients whose LDL-C goal should be <100 mg/dL or <70 mg/dL.3,4
Localization (history) of CHD in coronary artery associated with pressure and volume under development, nicotine addiction, coronary artery disease, atherosclerosis, diabetes mellitus, ischemia, increased venous pressure under development, disease, cva and disorder of lipid metabolism
7) Confidence 0.41 Published 2010 Journal Vascular Health and Risk Management Section Body Doc Link PMC2835557 Disease Relevance 1.88 Pain Relevance 0.15
The evidence for increasing TG as a means to decrease CHD is Grade A/B evidence based on randomized controlled trials and meta-analyses.



Localization (decrease) of CHD associated with coronary artery disease
8) Confidence 0.41 Published 2010 Journal Vascular Health and Risk Management Section Body Doc Link PMC2835557 Disease Relevance 0.68 Pain Relevance 0.04
A seventh “coronary heart disease” was inserted, then its abbreviation “CHD” and four conditions related to it and their abbreviations, where appropriate, all as separate keywords: “myocardial infarction,” “MI,” “coronary artery bypass graft,” “CABG,” “percutaneous transluminal coronary angioplasty,” “PTCA,” and “angina pectoris
Localization (abbreviation) of CHD in coronary artery associated with cva, coronary heart disease, myocardial infarction and percutaneous transluminal coronary angioplasty
9) Confidence 0.34 Published 2011 Journal Cardiology Research and Practice Section Body Doc Link PMC3010651 Disease Relevance 0.56 Pain Relevance 0.14
Genetic bases of CDH and MOH
Localization (bases) of CDH
10) Confidence 0.24 Published 2007 Journal J Headache Pain Section Body Doc Link PMC2779399 Disease Relevance 1.25 Pain Relevance 0.59
0.958), confirming the results of single SNP analyses that subjects with C allele of rs2236659 had lower risk of CHD (Table 4).


Localization (risk) of CHD associated with coronary artery disease
11) Confidence 0.14 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2838785 Disease Relevance 0.47 Pain Relevance 0
60 years and >60 years), sex and smoking status indicated that subjects with C allele of rs2236659 in men, older (>60 years) or smokers subgroups had significant lower risk of CHD.
Localization (risk) of CHD associated with coronary artery disease and nicotine addiction
12) Confidence 0.14 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2838785 Disease Relevance 1.03 Pain Relevance 0
Furthermore, for rs2774279 we also found evidence for association when analyzing prevalent female CHD cases in both cohorts combined (odds ratio of 1.58, 95% CI 1.04–2.40, p?
Spec (analyzing) Localization (cases) of CHD associated with coronary artery disease
13) Confidence 0.08 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2574036 Disease Relevance 0.74 Pain Relevance 0

[edit] General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox